Biotech · Private company · andover, MA, US
Evodenovo, Inc.
Track this companyFree. Adds Evodenovo, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development of small molecule therapeutics for mitigating opioid withdrawal syndrome Fiscal year 2026 · $687.3KNIH RePORTER 5R44DA053844-04 · fetched Nov 12, 2026
- Development of small molecule therapeutics for mitigating opioid withdrawal syndrome Fiscal year 2025 · $1.1MNIH RePORTER 5R44DA053844-03 · fetched Nov 12, 2026
- Development of small molecule therapeutics for mitigating opioid withdrawal syndromeFiscal year 2024 · $881KNIH RePORTER 2R44DA053844-02 · fetched Nov 12, 2026